Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial. [electronic resource]
Producer: 20200831Description: 710 p. digitalISSN:- 1745-6215
- Adaptive Clinical Trials as Topic
- Adolescent
- Adrenergic alpha-2 Receptor Agonists -- administration & dosage
- Age Factors
- Analgesics, Opioid -- administration & dosage
- Benzodiazepines -- administration & dosage
- Child
- Child, Preschool
- Dexmedetomidine -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Drug Tolerance
- Female
- Humans
- Hypnotics and Sedatives -- administration & dosage
- Infant
- Infant, Newborn
- Infusions, Intravenous
- Intensive Care Units, Pediatric
- Italy
- Male
- Multicenter Studies as Topic
- Opioid-Related Disorders -- diagnosis
- Randomized Controlled Trials as Topic
- Substance Withdrawal Syndrome -- diagnosis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.